These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2159186)

  • 1. Ifosfamide in testicular cancer.
    Loehrer PJ
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):2-5. PubMed ID: 2159186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide in testicular cancer: the Indiana University experience.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):96-101. PubMed ID: 2539649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
    Loehrer PJ; Lauer R; Roth BJ; Williams SD; Kalasinski LA; Einhorn LH
    Ann Intern Med; 1988 Oct; 109(7):540-6. PubMed ID: 2844110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.
    Farmakis D; Pectasides M; Pectasides D
    Eur Urol; 2005 Sep; 48(3):400-7. PubMed ID: 15964136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results.
    Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L
    Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
    Motzer RJ; Cooper K; Geller NL; Bajorin DF; Dmitrovsky E; Herr H; Morse M; Fair W; Sogani P; Russo P
    Cancer; 1990 Dec; 66(12):2476-81. PubMed ID: 2174300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ-cell tumors.
    Kondagunta V; Galsky MD; Sonpavde G
    N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969229
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial with etoposide (VP16) plus ifosfamide plus high-dose cisplatin (VIhP regimen) in refractory germ cell tumors.
    Droz JP; Ribrag V; Ghosn M; Guimares J; Theodore C; Azab M; Ostronoff M; Mahjoubi M; Moran A; Pico J
    Prog Clin Biol Res; 1989; 303():739-47. PubMed ID: 2550949
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage therapy in recurrent testicular cancer.
    Saxman S
    Semin Oncol; 1992 Apr; 19(2):143-7. PubMed ID: 1372756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience.
    Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience.
    Farhat F; Culine S; Théodore C; Békradda M; Terrier-Lacombe MJ; Droz JP
    Cancer; 1996 Mar; 77(6):1193-7. PubMed ID: 8635143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
    Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
    Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.
    Harstrick A; Schmoll HJ; Wilke H; Köhne-Wömpner CH; Stahl M; Schöber C; Casper J; Bruderek L; Schmoll E; Bokemeyer C
    J Clin Oncol; 1991 Sep; 9(9):1549-55. PubMed ID: 1651992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular cancer: an oncological success story.
    Einhorn EH
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2630-2. PubMed ID: 10068265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ifosfamide in testicular cancer.
    Schmoll HJ
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):82-95. PubMed ID: 2649987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for patients with poor prognosis germ cell tumors.
    Riese MJ; Vaughn DJ
    World J Urol; 2009 Aug; 27(4):471-6. PubMed ID: 19330334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S; Lee S; Lee J; Park SH; Park JO; Kang WK; Park YS; Lim HY
    Onkologie; 2011; 34(8-9):416-20. PubMed ID: 21934340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
    McCaffrey JA; Mazumdar M; Bajorin DF; Bosl GJ; Vlamis V; Motzer RJ
    J Clin Oncol; 1997 Jul; 15(7):2559-63. PubMed ID: 9215825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [VP-16 salvage therapy of PVB regimen-resistant testicular germ cell tumors].
    Yamazaki H; Yuichiro A; Kondo N; Imanaka K; Machida T
    Nihon Hinyokika Gakkai Zasshi; 1987 Jul; 78(7):1227-31. PubMed ID: 2446041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.